Table 2.
Authors (Years) [Reference] | Study Design | Overall Study Population | Sampling Methods | Detection Methods | Microbiome Association with Diverticular Disease | Treatment | Main Findings |
---|---|---|---|---|---|---|---|
Ponziani (2016) | Case-control | 20 consecutive patients (4 SUDD, 4 IBS, 4 CD, 4 UC, 4 HE) | Stool | 16S rRNA | Roseburia and Colinsella | Rifaximin | Significant increase in Roseburia and Colinsella (which decreased after rifaximin treatment) in SUDD). Significant reduction in Lactobacilli (which increased after rifaximin treatment) in SUDD. |
Tursi (2016) | Case-control | 44 consecutive patients (only women: 15 SUDD, 13 diverticulosis, 16 controls) | Stool | Real-time PCR | A. muciniphila | None | Significant increase in Akkermansia in SUDD compared with controls. |
Barbara (2017) | Case-control | 38 consecutive patients (8 SUDD, 14 diverticulosis, 16 controls) | Mucosal sampling during colonoscopy | 16S rRNA | Clostridium Cluster IX, Fusobacterium, and Lactobacillaceae | None | Significant decrease in Clostridium Cluster IX, Fusobacterium, and Lactobacillaceae in SUDD; A. muciniphila reduced in the diverticular district compared with the colonic district without diverticula. |
Lopetuso (2018) | Case-Control | 28 consecutive patients (4 SUDD, 3 IBS, 10 CD, 8 UC, 8 controls) | Stool | 16S rRNA | Bacteroides fragilis, Colinsella, and Riminococcaceae | None | Ruminococcaceae increased in SUDD, with depletion of Colinsella and Bacterioidetes fragilis. |
Linninge (2018) | Case-control | 51 consecutive patients (16 SUDD and 24 controls) | Mucosal sampling during colonoscopy | PCR-based profiling | Enterobacteriaceae | None | Increased abundance of Enterobacteriaceae in SUDD compared with controls. |
Kvasnovsky (2018) | Cohort | 30 consecutive SUDD patients (15 PD-SUDD and 15 NPD-SUDD) | Stool | 16S rRNA | Pseudobutyrivibrio Bifidobacterium, Christensenellaceae, Mollicutes RF9, Bacteroides, Faecalibacterium, and Ruminococcus | None | Bacteroides, Faecalibacterium, and Ruminococcus increased in all SUDD patients.
|
Laghi (2018) | Cohort | 13 consecutive SUDD patients (15 PD-SUDD and 15 NPD-SUDD) | Stool | Real-time PCR | Akkermansia muciniphila | Probiotic mixture, rifaximin, mesalazine, fibers | Significant decrease in Akkermansia under treatment, parallel with symptom improvement.
|
Ponziani (2020) | Case-control | 25 consecutive patients (7 SUDD, 8 IBS, 5 CD, 5 UC) | Stool | 16S rRNA | Faecalibacterium, Ruminococcus, and Roseburia | Rifaximin | Significant increase in Fecalibacterium and a significant decrease in Roseburia and Ruminococcus in patients responding to rifaximin. |
Tursi (2022) | Case-control | 44 consecutive patients (only women: 15 SUDD, 13 diverticulosis, 16 controls) | Stool | Real-time PCR | F. prausnitzii | None | Slight increase (not significant) in F. prausnitzii in SUDD compared with controls. |
Abbreviations: SUDD, symptomatic uncomplicated diverticular disease; PD-SUDD, post diverticulitis symptomatic uncomplicated diverticular disease; NPD-SUDD, non-post diverticulitis symptomatic uncomplicated diverticular disease; HE, hepatic encephalopathy; IBS, irritable bowel syndrome; CD, Crohn’s disease; UC, ulcerative colitis.